Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Metformin; Thiazolidinediones
- Indications Obesity
- Focus Pharmacodynamics
- 03 Dec 2014 Biomarkers information updated
- 25 Jul 2013 Planned End Date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 12 Jun 2008 Actual initiation date for this trial is Jul 2007 as reported by ClinicalTrials.gov